Ligand Pharmaceuticals: Peers

The FY2023 (Dec) proxy of Ligand Pharmaceuticals names 18 peer companies for pay. Pay versus performance data of Ligand Pharmaceuticals for that year is not on file, so it has no rank.

Pay peer group, FY2023 (Dec) proxy

Collegium Pharmaceutical
Travere Therapeutics
Agios Pharmaceuticals
Innoviva
Axsome TherapeuticsNot disclosedNot disclosed
Catalyst PharmaceuticalsNot disclosedNot disclosed
Coherus BioSciencesNot disclosedNot disclosed
Corcept TherapeuticsNot disclosedNot disclosed
Deciphera PharmaceuticalsNot disclosedNot disclosed
Heron TherapeuticsNot disclosedNot disclosed
Intercept PharmaceuticalsNot disclosedNot disclosed
Ironwood PharmaceuticalsNot disclosedNot disclosed
REGENXBIONot disclosedNot disclosed
Rhythm PharmaceuticalsNot disclosedNot disclosed
Theravance BiopharmaNot disclosedNot disclosed
Vanda PharmaceuticalsNot disclosedNot disclosed
VericelNot disclosedNot disclosed
XencorNot disclosedNot disclosed
18 companies

PSU comparator group

The companies that relative total shareholder return is measured against for performance stock units.

NASDAQ Biotechnology Index (index)Not disclosedNot disclosed
1 company

Changes by year

FY2023 (Dec) proxy

  • AddedAxsome Therapeuticspay peer groupdue to their alignment with the peer group selection criteria
  • AddedCatalyst Pharmaceuticalspay peer groupdue to their alignment with the peer group selection criteria
  • AddedCollegium Pharmaceuticalpay peer groupdue to their alignment with the peer group selection criteria
  • AddedDeciphera Pharmaceuticalspay peer groupdue to their alignment with the peer group selection criteria
  • AddedIntercept Pharmaceuticalspay peer groupdue to their alignment with the peer group selection criteria
  • AddedRhythm Pharmaceuticalspay peer groupdue to their alignment with the peer group selection criteria
  • AddedTheravance Biopharmapay peer groupdue to their alignment with the peer group selection criteria
  • AddedTravere Therapeuticspay peer groupdue to their alignment with the peer group selection criteria
  • AddedVanda Pharmaceuticalspay peer groupdue to their alignment with the peer group selection criteria
  • AddedVericelpay peer groupdue to their alignment with the peer group selection criteria
  • RemovedBerkeley Lightspay peer groupsince their trailing 12-month revenues, market capitalizations and/or headcount were positioned outside of the peer group selection criteria
  • RemovedCodexispay peer groupsince their trailing 12-month revenues, market capitalizations and/or headcount were positioned outside of the peer group selection criteria
  • RemovedHalozyme Therapeuticspay peer groupsince their trailing 12-month revenues, market capitalizations and/or headcount were positioned outside of the peer group selection criteria
  • RemovedNektar Therapeuticspay peer groupsince their trailing 12-month revenues, market capitalizations and/or headcount were positioned outside of the peer group selection criteria
  • RemovedPTC Therapeuticspay peer groupsince their trailing 12-month revenues, market capitalizations and/or headcount were positioned outside of the peer group selection criteria
  • RemovedPacira BioSciencespay peer groupsince their trailing 12-month revenues, market capitalizations and/or headcount were positioned outside of the peer group selection criteria
  • RemovedSchrpay peer groupsince their trailing 12-month revenues, market capitalizations and/or headcount were positioned outside of the peer group selection criteria
  • RemovedSupernus Pharmaceuticalspay peer groupsince their trailing 12-month revenues, market capitalizations and/or headcount were positioned outside of the peer group selection criteria
  • RemovedTwist Biosciencepay peer groupsince their trailing 12-month revenues, market capitalizations and/or headcount were positioned outside of the peer group selection criteria
  • RemovedUltragenyx Pharmaceuticalpay peer groupsince their trailing 12-month revenues, market capitalizations and/or headcount were positioned outside of the peer group selection criteria

The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year. Each company counts TSR from its own start year, so two values compare only when the start years match.